Day Zero Diagnostics

Day Zero Diagnostics

Medical Devices, 2111 Ne 25th Ave, Boston, Massachusetts, 97124, United States, 51-200 Employees

dayzerodiagnostics.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 61********

Who is DAY ZERO DIAGNOSTICS

The future of infectious disease diagnostics starts at Day Zero. By using whole-genome sequencing (WGS) and our proprietary enabling technologies, Day Zero is creating a new class of sequ...

Read More

map
  • 2111 Ne 25th Ave, Boston, Massachusetts, 97124, United States Headquarters: 2111 Ne 25th Ave, Boston, Massachusetts, 97124, United States
  • 2016 Date Founded: 2016
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $1 Billion and Over
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 3577 | NAICS Code: 334413 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from DAY ZERO DIAGNOSTICS

Day Zero Diagnostics Org Chart and Mapping

Employees

Alison Gassett

Clinical Laboratory Supervisor - Lab Services

Adam Gardner

Principal Data Engineer

Emily Macleod

Senior Research Associate I

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Day Zero Diagnostics

Answer: Day Zero Diagnostics's headquarters are located at 2111 Ne 25th Ave, Boston, Massachusetts, 97124, United States

Answer: Day Zero Diagnostics's phone number is 61********

Answer: Day Zero Diagnostics's official website is https://dayzerodiagnostics.com

Answer: Day Zero Diagnostics's revenue is $1 Billion and Over

Answer: Day Zero Diagnostics's SIC: 3577

Answer: Day Zero Diagnostics's NAICS: 334413

Answer: Day Zero Diagnostics has 51-200 employees

Answer: Day Zero Diagnostics is in Medical Devices

Answer: Day Zero Diagnostics contact info: Phone number: 61******** Website: https://dayzerodiagnostics.com

Answer: The future of infectious disease diagnostics starts at Day Zero. By using whole-genome sequencing (WGS) and our proprietary enabling technologies, Day Zero is creating a new class of sequencing-based in-vitro diagnostics that generates clinically actionable data at scale. Our technologies include novel sample preparation methods enabling unprecedented ultra-high enrichment of pathogen DNA for sequencing directly from clinical samples, machine learning algorithms that provide clinically actionable diagnostic results, and a world-class database of WGS and drug efficacy profiles. Day Zero Diagnostics is on a mission to transform the way infectious disease diagnostics are performed by generating the stream of real-time sequencing data required to change how we track, manage and combat infectious diseases. With an enormous unmet clinical and economic need, we are targeting bloodstream infections and sepsis for our first application. The life expectancy of a patient with septic shock is 24 hours without fast effective antibiotic treatment. However, even when successful, current diagnostics take 2-5 days to identify the pathogen AND provide its antibiotic susceptibility profile. The lack of rapid, accurate, and comprehensive diagnostics, forces physicians to carpet bomb patients with severe infections with powerful, yet toxic, broad-spectrum antibiotics, which is not only ineffective in many cases but can also lead to significant morbidity and mortality. Day Zero delivers a complete diagnosis, including both the species and antibiotic resistance profile, in hours vs. days, enabling the physician to use a targeted treatment on day zero of hospital admission and resulting in better patient outcomes and cost savings.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access